Chandelier
Senior Member (Voting Rights)
Homepage - Point
Mitigating long-term health risks: the POINT project approach The POINT project offers pioneering strategies to minimise the risk of long-term consequences following COVID-19 and other severe infections in general. Understanding the risks The post-acute phase of COVID-19 can lead to severe...
point-health.eu
POINT: personalised care for post-COVID-19 health
POINT, a European Union-funded initiative, aims to improve the outcomes of people who have had COVID-19 by conducting research into its long-term effects. Through advanced biomarkers and a virtual twin model, we will personalise care for survivors, predict future health complications, and develop standardised guidelines for healthcare professionals. Join us in our mission to improve the lives of millions of patients.Overview
POINT is an innovative research project funded by the European Union with a mission to mitigate the long-term health risks associated with COVID-19. By harnessing advanced biomarkers and a virtual twin model for personalized care, we aim to bridge the gap between scientific discoveries and their practical application in clinical settings. Our goal is to gain a comprehensive understanding of the post-acute phase of COVID-19 and equip healthcare professionals with the necessary tools and guidelines to effectively manage patients.Objectives
Exploring the mechanistic link and risk factors
POINT will delve into the relationship between the post-acute phase of COVID-19 and the emergence of non-communicable diseases (NCDs), with a focus on the pulmonary, cardiovascular, and renal systems. Through the analysis of extensive cohort studies and biobanks, we aim to shed light on the clinical, biological, and socioeconomic factors that contribute to this heightened risk.Developing biomarkers and predictive tools
POINT will identify and validate biomarkers as early indicators of health complications in COVID-19 survivors. We will develop a virtual twin model to replicate tissue function post-infection, facilitating timely assessments and preventive actions. These tools will help to forecast the influence of comorbidities and medication, and to track disease progression and the underlying causes.Establishing standardised guidelines
POINT will create guidelines for healthcare professionals to optimise risk management and preventive care strategies. These guidelines will be adapted to European and international standards, with an emphasis on the inclusion of vulnerable populations. Feasibility studies and continuous adherence assessments will ensure that the guidelines are fit for purpose.Impact
POINT has the potential to revolutionise our approach to post-COVID-19 health issues. This research project offers a promising opportunity for healthcare professionals and authorities in Europe to improve how they manage these challenges.Through POINT, we will:
- Optimise the management of patients and alleviate the societal burden of non-communicable diseases
- Lead to early identification and effective treatment of patients at risk, ensuring a higher quality of life
- Promote greater patient inclusion and adherence to the guidelines developed
- Offer insights applicable to other infectious diseases and non-communicable diseases
- Empower citizens and patients with health literacy, encouraging them to seek advice and reducing the risk of non-communicable diseases after COVID-19
- Ensure that millions of patients receive the attention and treatment they need to prevent long-term health complications
Project Team
The project is coordinated by the University of Copenhagen (UCPH) and run by an interdisciplinary team of ten organisations across Europe. This team draws on the expertise of clinical, molecular, behavioural scientists and computer scientists.Claus Desler
Associate Professorcdesler@sund.ku.dk
Kobenhavns Universitet
(Denmark)
Ove Andersen
Professor, Head of Research at Department of Clinical Researchove.andersen@regionh.dk
Region Hovedstaden
(Denmark)
Pärt Peterson
PhD, Professor at Institute of Biomedicine and Translational Medicinepart.peterson@ut.ee
Tartu Ulikool
(Estonia)
Florian Lange
Postdoctoral Researcher and Research Managerflorian.lange@kuleuven.be
Katholieke Universiteit Leuven
(Belgium)
Lena Krieger
Dipl.-Ing., Senior Project Managerlena.krieger@din.de
Deutsches Institut Für Normung
(Germany)
Evangelos J. Giamarellos-Bourboulis
MD, PhD, FISAC, Professor of Internal Medicine and Infectious Diseasesegiamarel@med.uoa.gr
Hellenic Institute for the Study of Sepsis
(Greece)
Chiara Palazzetti
Project manager officerchiara.palazzetti@icons.it
Fondazione ICONS
(Italy)
Shlomo Vinker
Professor, MD, MHA, WONCA Europe Presidentpresident@woncaeurope.org
Stitching Wonca Europe
(Slovenia)
Asger Væring Larsen
Special Adviseravla@kb.dk
Det Kgl. Bibliotek
(Denmark)
Kristina Djordjevic
MSc., Bioinformatics Strategy and Life Sciences Project Leadkristina@biofi.ch
Biofi Ag
(Switzerland)
